コンテンツへスキップ
Merck
  • Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia.

Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia.

Leukemia (2001-03-13)
T A McDonald, N T Holland, C Skibola, P Duramad, M T Smith
要旨

High background levels of phenol and hydroquinone are present in the blood and urine of virtually all individuals, but vary widely. Phenol and hydroquinone have been strongly implicated in producing leukemia associated with benzene exposure, because they reproduce the hematotoxicity of benzene, cause DNA and chromosomal damage found in leukemia, inhibit topoisomerase II, and alter hematopoiesis and clonal selection. The widely varying background levels of phenol and hydroquinone in control individuals stem mainly from direct dietary ingestion, catabolism of tyrosine and other substrates by gut bacteria, ingestion of arbutin-containing foods, cigarette smoking, and the use of some over-the-counter medicines. We hypothesize that these background sources of phenol and hydroquinone and associated adducts play a causal role in producing some forms of de novo leukemia in the general population. This hypothesis is consistent with recent epidemiological findings associating leukemia with diets rich in meat and protein, the use of antibiotics (which change gastrointestinal flora make-up), lack of breastfeeding, and low activity of NAD(P)H quinone oxidoreductase which detoxifies quinones derived from phenol and hydroquinone and protects against benzene hematotoxicity. An attractive feature of our hypothesis is that it may explain why many people who have no known occupational exposures or significant smoking history develop leukemia. The hypothesis predicts that susceptibility to the disease would be related to diet, medicinal intake, genetics and gut-flora composition. The latter two of these are largely beyond our control, and thus dietary modification and reduced use of medicines that elevate phenol levels may be the best intervention strategies for lowering leukemia risk.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
フェノール 溶液, BioReagent, Equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA, for molecular biology
Sigma-Aldrich
フェノール 溶液, BioReagent, Saturated with 0.01 M citrate buffer, pH 4.3 ± 0.2, for molecular biology
Supelco
フェノール 溶液, certified reference material, 500 μg/mL in methanol
Sigma-Aldrich
フェノール, BioUltra, for molecular biology, TE-saturated, ~73% (T)
Sigma-Aldrich
ヒドロキノン, ReagentPlus®, ≥99%
Supelco
フェノール 溶液, 5000 μg/mL in methanol, certified reference material
Sigma-Aldrich
フェノール, SAJ first grade, ≥98.0%
Sigma-Aldrich
フェノール, puriss. p.a., ACS reagent, reag. Ph. Eur., 99.0-100.5%
USP
ヒドロキノン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
液体フェノール, ≥89.0%
Sigma-Aldrich
ヒドロキノン, SAJ first grade, ≥99.0%
Sigma-Aldrich
フェノール, for molecular biology
Sigma-Aldrich
ヒドロキノン, ReagentPlus®, 99%
Sigma-Aldrich
ヒドロキノン, JIS special grade, ≥99.0%
Sigma-Aldrich
フェノール, puriss., ≥99.5% (GC), meets analytical specification of Ph. Eur., BP, USP, crystalline (detached)
Supelco
フェノール, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
フェノール, BioXtra, ≥99.5% (GC)
Sigma-Aldrich
フェノール標準原液, 100 mg/dL, standard
Sigma-Aldrich
フェノール, contains hypophosphorous as stabilizer, loose crystals, ACS reagent, ≥99.0%
Sigma-Aldrich
フェノール, unstabilized, ReagentPlus®, ≥99%
Supelco
フェノール, PESTANAL®, analytical standard
Sigma-Aldrich
フェノール, JIS special grade, ≥99.0%
Sigma-Aldrich
フェノール, ≥99.0%
Sigma-Aldrich
フェノール, ≥96.0% (calc. on dry substance, T)
Sigma-Aldrich
パンディ試薬
Sigma-Aldrich
フェノール, unstabilized, purified by redistillation, ≥99%
Sigma-Aldrich
フェノール, ≥99.0%
Sigma-Aldrich
ヒドロキノン, meets USP testing specifications
Supelco
フェノール 溶液, 100 μg/mL in acetonitrile, PESTANAL®, analytical standard
Sigma-Aldrich
フェノール, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.5-100.5% (GC)